ATAI Life Sciences and Cyclica launch joint venture to revolutionise drug development for mental health disorders
Entheogenix Biosciences Inc, the Delaware-based company jointly-founded as part of the venture, will leverage Cyclica’s proprietary technology to design and synthesize new compounds from psychoactive seed small molecule